Delivery Order SPE2DB20D3303-SPE2DB25FA3KZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,506.82 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count package) on September 10, 2025, with completion scheduled for September 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count units) under a firm fixed-price contract with a ceiling value of $5,359.73. This non-competitive delivery order is set to be completed by August 25, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's role as a critical...
- The Defense Logistics Agency awarded a $7,996.94 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of July 29, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under a larger contract vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Entresto 97 mg-103 mg tablets (180-count units) valued at $3,243.28. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded contract. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is a child contract executed under a larger...
- The Defense Logistics Agency awarded a $3,689.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Entresto 24 mg-26 mg tablets (60-count supply) on July 18, 2025, with an ultimate completion date of July 21, 2025. This non-competitive delivery order was placed against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,962.22 on August 4, 2025, for the supply of Entresto 24 mg-26 mg tablets (180-count). This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at approximately $29,471 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (60-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $22,232.86 to supply Entresto 97 mg-103 mg tablets (180-count) with an ultimate completion date of August 19, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor serving military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $8,037.83 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (180-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $6,279.78 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Entresto 49 mg-51 mg tablets (180-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3KZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,924.05 to AmerisourceBergen Drug Corp for the supply of Entresto 97 mg-103 mg tablets (60-count packaging) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order supports the Defense Logistics Agency's Medical Supply Chain mission to provision pharmaceutical products for military and veteran healthcare systems. Entresto, a combination medication used in heart failure management, represents the type of specialized pharmaceutical commodity that AmerisourceBergen regularly supplies through its comprehensive federal contract portfolio. The award reflects the contractor's established capability to fulfill federal medical procurement requirements through open competition and underscores its role as a critical vendor for the Department of Defense's healthcare logistics operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/8/25 |